Nigericin

Revision as of 19:03, 27 September 2011 by WikiBot (talk | contribs) (Protected "Nigericin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Nigericin

Articles

Most recent articles on Nigericin

Most cited articles on Nigericin

Review articles on Nigericin

Articles on Nigericin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Nigericin

Images of Nigericin

Photos of Nigericin

Podcasts & MP3s on Nigericin

Videos on Nigericin

Evidence Based Medicine

Cochrane Collaboration on Nigericin

Bandolier on Nigericin

TRIP on Nigericin

Clinical Trials

Ongoing Trials on Nigericin at Clinical Trials.gov

Trial results on Nigericin

Clinical Trials on Nigericin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Nigericin

NICE Guidance on Nigericin

NHS PRODIGY Guidance

FDA on Nigericin

CDC on Nigericin

Books

Books on Nigericin

News

Nigericin in the news

Be alerted to news on Nigericin

News trends on Nigericin

Commentary

Blogs on Nigericin

Definitions

Definitions of Nigericin

Patient Resources / Community

Patient resources on Nigericin

Discussion groups on Nigericin

Patient Handouts on Nigericin

Directions to Hospitals Treating Nigericin

Risk calculators and risk factors for Nigericin

Healthcare Provider Resources

Symptoms of Nigericin

Causes & Risk Factors for Nigericin

Diagnostic studies for Nigericin

Treatment of Nigericin

Continuing Medical Education (CME)

CME Programs on Nigericin

International

Nigericin en Espanol

Nigericin en Francais

Business

Nigericin in the Marketplace

Patents on Nigericin

Experimental / Informatics

List of terms related to Nigericin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Nigericin is an antibiotic derived from Streptomyces hygroscopicus. Commercially it is obtained as a byproduct, or contaminant, at the fermentation of Geldanamycin. It is also called Polyetherin A, Azalomycin M, Helixin C, Antibiotic K178, Antibiotic X-464.

Nigericin acts as an H+, K+, Pb++ ionophore. It most commonly is an antiporter of H+ and K+.

In the past Nigericin was used as an antibiotic active against gram positive bacteria. It inhibits the Golgi functions. Nigericin exhibits anti-HIV activity.

Properties

  • CAS number: 28643-80-3
  • Merck index: 12, 6633
  • Molecular weight: 747
  • Formula C40H67O11Na

The properties are copied from a manufacturer's Nigericin product page]

External references


Template:SIB

Template:WH Template:WikiDoc Sources